Serum interferon-gamma-inducible protein 10 level was increased in myocardial infarction patients, and negatively correlated with infarct size

Kazuya Koten, Satoshi Hirohata, Toru Miyoshi, Hiroko Ogawa, Shinichi Usui, Ryoko Shinohata, Mutsumi Iwamoto, Tomoki Kitawaki, Shozo Kusachi, Kosaku Sakaguchi, Tohru Ohe

Research output: Contribution to journalArticle

18 Citations (Scopus)

Abstract

Objectives: We examined the serum levels of interferon-gamma-inducible protein 10 (IP-10), an inflammation-induced chemokine, in acute myocardial infarction (AMI). Design and methods: The subjects were 33 AMI patients, 20 stable angina pectoris patients (AP) and 20 normal subjects. In AMI patients, blood samples were collected before percutaneous coronary intervention (PCI) and on days 3, 7 and 28. Results: Patients with AMI showed significantly higher serum IP-10 levels (137.5 ± 79.8 pg/mL) than control subjects (91.2 ± 40.1 pg/mL) and patients with AP (93.3 ± 41.1 pg/mL). The serum IP-10 level before PCI was negatively correlated with infarct size, as indicated by cumulative release of creatine kinase (CK) and peak CK and its isoenzyme CK-MB. Stepwise multiple regression analysis revealed that the serum IP-10 level before PCI was an independent predictor of cumulative CK release. Conclusions: The serum IP-10 level was increased in AMI, and a higher level of serum IP-10 before PCI may be informative regarding infarct size.

Original languageEnglish
Pages (from-to)30-37
Number of pages8
JournalClinical Biochemistry
Volume41
Issue number1-2
DOIs
Publication statusPublished - Jan 1 2008

Keywords

  • Chemokines
  • Coronary disease
  • Diagnosis
  • Immunoassay
  • Inflammation

ASJC Scopus subject areas

  • Clinical Biochemistry

Fingerprint Dive into the research topics of 'Serum interferon-gamma-inducible protein 10 level was increased in myocardial infarction patients, and negatively correlated with infarct size'. Together they form a unique fingerprint.

  • Cite this